Skip to main content
Contact Us
Subscribe
E-Edition
82°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
January 16, 2025
Tickers
NEWS
REGN
Tags
Market News
Benzinga
REGN
From
Benzinga
Regeneron Pipeline Aims To Address $220 Billion Therapeutic Opportunities By 2030
January 14, 2025
Tickers
NEWS
REGN
Tags
Briefs
Biotech
Benzinga
From
Benzinga
Forecasting The Future: 22 Analyst Projections For Regeneron Pharmaceuticals
January 10, 2025
Tickers
REGN
Tags
BZI/AAR
REGN
Benzinga
From
Benzinga
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
January 09, 2025
Tickers
AMGN
BMY
GILD
LLY
Tags
News
Health Care
Market News
From
Benzinga
What Analysts Are Saying About Regeneron Pharmaceuticals Stock
January 08, 2025
Tickers
REGN
Tags
BZI/AAR
REGN
Benzinga
From
Benzinga
1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street
January 02, 2025
Tickers
REGN
Tags
Recent Press Releases
REGN
Market News
From
Motley Fool
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
December 23, 2024
Tickers
NEWS
REGN
Tags
Market News
REGN
Benzinga
From
Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
December 22, 2024
Tickers
ABBV
BMY
ELAN
GILD
Tags
News
MRK
Analyst Color
From
Benzinga
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
December 17, 2024
Tickers
BAYRY
NEWS
REGN
Tags
Large Cap
Stories That Matter
Biotech
From
Benzinga
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
December 17, 2024
Tickers
APA
ASML
AVGO
CEG
Tags
QQQ
NXP
TSLA
From
Benzinga
What 25 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
December 17, 2024
Tickers
REGN
Tags
BZI/AAR
Benzinga
REGN
From
Benzinga
Jim Cramer: This Energy Stock Is A 'Winner,' But Navitas Semiconductor Is 'Losing A Lot Of Money'
December 04, 2024
Tickers
LB
LLY
NEWS
NVTS
Tags
LB
LLY
Benzinga
From
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity
November 26, 2024
Tickers
REGN
Tags
Market News
Markets
BZI/UOA
From
Benzinga
Regeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinking
November 19, 2024
Tickers
REGN
Tags
Options
BZI/UOA
Markets
From
Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
November 18, 2024
Tickers
REGN
Tags
BZI/SHORTHIST
Short Ideas
Trading Ideas
From
Benzinga
Check Out What Whales Are Doing With REGN
November 15, 2024
Tickers
REGN
Tags
Market News
REGN
BZI/UOA
From
Benzinga
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
November 15, 2024
Tickers
NEWS
REGN
SNY
Tags
Large Cap
Stories That Matter
Benzinga
From
Benzinga
28 Analysts Have This To Say About Regeneron Pharmaceuticals
November 14, 2024
Tickers
REGN
Tags
Market News
Analyst Ratings
REGN
From
Benzinga
2 Top Growth Stocks to Buy on the Dip
November 14, 2024
Tickers
LLY
REGN
Tags
Recent Press Releases
LLY
Market News
From
Motley Fool
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
November 13, 2024
Tickers
AZN
GSK
NEWS
REGN
Tags
AZN
Benzinga
FDA
From
Benzinga
Assessing Regeneron Pharmaceuticals's Performance Against Competitors In Biotechnology Industry
November 06, 2024
Tickers
NEWS
REGN
Tags
Markets
REGN
Benzinga
From
Benzinga
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
November 06, 2024
Tickers
ASML
DELL
IDXX
MRNA
Tags
REGN
IDXX
ASML
From
Motley Fool
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
November 05, 2024
Tickers
AMGN
AZN
NEWS
REGN
Tags
Analyst Ratings
Trading Ideas
Benzinga
From
Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
November 04, 2024
Tickers
REGN
Tags
Market News
Benzinga
Markets
From
Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
October 31, 2024
Tickers
NEWS
NVO
REGN
SNY
Tags
News
Health Care
Market News
From
Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
October 31, 2024
Tickers
AAPL
AMGN
AMZN
BKNG
Tags
Mid Cap
AMZN
EBAY
From
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Tickers
ABBV
AMGN
BIIB
BMY
Tags
NVS
Market News
Health Care
From
Benzinga
EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss
October 28, 2024
Tickers
EYPT
NEWS
REGN
Tags
Market News
News
Health Care
From
Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
October 28, 2024
Tickers
AMGN
CMG
GS
LLY
Tags
REGN
GS
LLY
From
Motley Fool
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
October 25, 2024
Tickers
LLY
NEWS
REGN
SNY
Tags
SNY
General
Briefs
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
